
AMEXHealthcareDrug Manufacturers - Specialty & Generic
最新数据
US$0.3379
−US$0.0183 · -5.14%
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
常规交易时段
US$0.3379
−US$0.0183 · -5.14%
盘中时间采用ET。市场数据可能有所延迟。
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
日内区间
当前US$0.3379
52周区间
当前US$0.3379
盘中时间采用ET。市场数据可能有所延迟。
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
日内区间
当前US$0.3379
52周区间
当前US$0.3379
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1919.05万 USD | 1948.22万 USD | 2415.54万 USD | 3540.32万 USD | 4448.08万 USD |
| 销货成本 | 722.22万 USD | 863.65万 USD | 1111.88万 USD | 1490万 USD | 1551.25万 USD |
| 毛利 | 1196.83万 USD | 1084.57万 USD | 1303.65万 USD | 2050.33万 USD | 2896.83万 USD |
| 研究与开发 | 3.39万 USD | — | — | — | — |
| 销售、一般及管理费用 | 1143.42万 USD | 1403.53万 USD | 2230.51万 USD | 3781.38万 USD | 4858.43万 USD |
| 营业费用 | 1413.08万 USD | 1403.53万 USD | 2230.51万 USD | 3781.38万 USD | 4858.43万 USD |
| 利息收入 | 3.43万 USD | — | 6.37万 USD | 1.62万 USD | — |
| 利息支出 | — | 2.95万 USD | — | — | 2.89万 USD |
| 折旧和摊销 | 179.59万 USD | 182.05万 USD | 292.77万 USD | 297.05万 USD | 225.38万 USD |
| 营业利润 | −216.26万 USD | −318.96万 USD | −926.85万 USD | −1731.05万 USD | −1961.6万 USD |
| 净利润 | −204.09万 USD | −370.01万 USD | −2293.82万 USD | −7008.37万 USD | −2339.49万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。